Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 13, 2018

Total Value ($000): $553,249 (100.0% shares, 0.0% debt)

Holdings (9)

— REVANCE THERAPEUTICS INC 24.8%

Value ($000) $137,353 Shares 3,842,047 Est. Cost $31.50 Unrealized —

— ABIOMED INC 21.9%

Value ($000) $121,220 Shares 646,818 Est. Cost $21.56 Unrealized —

AXGN AXOGEN INC 19.0%

Value ($000) $105,024 Shares 3,711,111 Est. Cost $4.01 Unrealized +489.0%

— CORIUM 16.2%

Value ($000) $89,885 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENTELLUS MEDICAL INC 14.0%

Value ($000) $77,560 Shares 3,231,656 Est. Cost $21.90 Unrealized —

— ENDOLOGIX INC 2.3%

Value ($000) $12,761 Shares 1,257,468 Est. Cost $18.00 Unrealized —

MNOV MEDICINOVA INC 1.4%

Value ($000) $7,572 Shares 1,170,370 Est. Cost $2.95 Unrealized +124.9%

— CATALYST 0.2%

Value ($000) $1,091 Shares 78,622 Est. Cost $4.80 Unrealized —

ACUR ACURA PHARMACEUTICALS INC 0.1%

Value ($000) $783 Shares 1,956,397 Est. Cost $3.40 Unrealized -87.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	REVANCE THERAPEUTICS INC	3,842,047	$137,353	24.8%	$31.50	—	COM	761330109
—	ABIOMED INC	646,818	$121,220	21.9%	$21.56	—	COM	003654100
AXGN	AXOGEN INC	3,711,111	$105,024	19.0%	$4.01	+489.0%	COM	05463X106
—	CORIUM	9,353,304	$89,885	16.2%	$7.77	—	COM	21887L107
—	ENTELLUS MEDICAL INC	3,231,656	$77,560	14.0%	$21.90	—	COM	29363K105
—	ENDOLOGIX INC	1,257,468	$12,761	2.3%	$18.00	—	COM	29266S106
MNOV	MEDICINOVA INC	1,170,370	$7,572	1.4%	$2.95	+124.9%	COM	58468P206
—	CATALYST	78,622	$1,091	0.2%	$4.80	—	COM	14888D109
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$783	0.1%	$3.40	-87.9%	COM	00509L802